Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehran Baghi

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Head & Neck|November 24, 2006
Inverse correlation between serum PGE2 and T classification in head and neck cancerMarkus Hambek, Mehran Baghi, Jens Wagenblast, et al.
Anticancer Research|February 26, 2004
EGFR antibody-supplemented TPE-chemotherapy. Preclinical investigations to a novel approach for head and neck cancer induction treatmentRainald Knecht, Silke Peters, Christine Solbach, et al.
Anticancer Research|November 29, 2005
Reduction of cisplatin dosage by ZD 1839Markus Hambek, Mehran Baghi, Klaus Strebhardt, et al.
Advances in Oto-Rhino-Laryngology|December 21, 2004
EGFR-antibody-supplemented TPF chemotherapy. Preclinical investigations to a novel approach for head and neck cancer induction treatmentRainald Knecht, Silke Peters, Markus Hambek, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|January 6, 2026
Stem cell-based and gene editing strategies in the treatment of congenital and acquired sensorineural hearing loss: a narrative reviewAlireza Moradi, Seied-Reza Seied-Mohammad Doulabi, Ashkan Sherafat Vaziri, et al.
Journal of Cancer Research and Clinical Oncology|August 19, 2007
Antiproliferative activity of bortezomib alone and in combination with cisplatin or docetaxel in head and neck squamous cell carcinoma cell linesJens Wagenblast, Markus Hambek, Mehran Baghi, et al.
Anticancer Research|March 8, 2011
Heterogeneity of primary site biopsies in head and neck squamous cell carcinomaSusanne Moertel, Hanns Ackermann, Mehran Baghi, et al.
Anticancer Research|August 17, 2005
The efficacy of MRI with ultrasmall superparamagnetic iron oxide particles (USPIO) in head and neck cancersMehran Baghi, Martin G Mack, Markus Hambek, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 15, 2008
Gadolinium-enhanced echo-planar T2-weighted MRI of tumors in the extracranial head and neck: feasibility study and preliminary results using a distributed-parameter tracer kinetic analysisSotirios Bisdas, Mehran Baghi, Jens Wagenblast, et al.
Anticancer Research|August 30, 2008
Craniofacial reconstructions with bone-anchored epithesis in head and neck cancer patients--a valid way back to self-perception and social reintegrationJens Wagenblast, Mehran Baghi, Matthias Helbig, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Head & Neck|November 24, 2006
Inverse correlation between serum PGE2 and T classification in head and neck cancerMarkus Hambek, Mehran Baghi, Jens Wagenblast, et al.
Anticancer Research|February 26, 2004
EGFR antibody-supplemented TPE-chemotherapy. Preclinical investigations to a novel approach for head and neck cancer induction treatmentRainald Knecht, Silke Peters, Christine Solbach, et al.
Anticancer Research|November 29, 2005
Reduction of cisplatin dosage by ZD 1839Markus Hambek, Mehran Baghi, Klaus Strebhardt, et al.
Advances in Oto-Rhino-Laryngology|December 21, 2004
EGFR-antibody-supplemented TPF chemotherapy. Preclinical investigations to a novel approach for head and neck cancer induction treatmentRainald Knecht, Silke Peters, Markus Hambek, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|January 6, 2026
Stem cell-based and gene editing strategies in the treatment of congenital and acquired sensorineural hearing loss: a narrative reviewAlireza Moradi, Seied-Reza Seied-Mohammad Doulabi, Ashkan Sherafat Vaziri, et al.
Journal of Cancer Research and Clinical Oncology|August 19, 2007
Antiproliferative activity of bortezomib alone and in combination with cisplatin or docetaxel in head and neck squamous cell carcinoma cell linesJens Wagenblast, Markus Hambek, Mehran Baghi, et al.
Anticancer Research|March 8, 2011
Heterogeneity of primary site biopsies in head and neck squamous cell carcinomaSusanne Moertel, Hanns Ackermann, Mehran Baghi, et al.
Anticancer Research|August 17, 2005
The efficacy of MRI with ultrasmall superparamagnetic iron oxide particles (USPIO) in head and neck cancersMehran Baghi, Martin G Mack, Markus Hambek, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 15, 2008
Gadolinium-enhanced echo-planar T2-weighted MRI of tumors in the extracranial head and neck: feasibility study and preliminary results using a distributed-parameter tracer kinetic analysisSotirios Bisdas, Mehran Baghi, Jens Wagenblast, et al.
Anticancer Research|August 30, 2008
Craniofacial reconstructions with bone-anchored epithesis in head and neck cancer patients--a valid way back to self-perception and social reintegrationJens Wagenblast, Mehran Baghi, Matthias Helbig, et al.
Pageof 4